Clinical Trials Directory

Trials / Completed

CompletedNCT04701125

Medical Cooling of Ice Hockey Players

Selective Head-neck Cooling Following Concussion Shortens Return-to-play in Ice Hockey Players

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The incidence of Sports-related concussions (SRCs) has risen in recent years, not least in ice hockey, and available treatment options are limited. Here, we addressed the hypotheses that immediate controlled head- and neck cooling could hasten return-to-play in a Swedish cohort of concussed professional ice hockey players. Over three seasons, 15 teams used either immediate head- and neck cooling or standard management for SRC. All players (81) followed the same return-to-play management protocol.

Detailed description

Sports-related concussions (SRCs) are a growing health concern, since they may lead to persistent symptoms and, particularly if repeated, to e.g. depression, accelerated dementia onset, and development of chronic traumatic encephalopathy. Here, we addressed the hypotheses that immediate controlled head- and neck cooling could hasten return-to-play in a Swedish cohort of concussed professional ice hockey players. Over three seasons, 15 teams used either immediate head- and neck cooling or standard management for SRC. All players followed the same return-to-play management protocol. Using a baseline questionnaire, no difference in the number of previous SRCs between groups was observed. In total, 92 SRCs were recorded. Eleven players did not complete the study protocol, and thus 81 players were included. Of these, 29 were treated by immediate selective head- and neck cooling for ≥ 30 min, and 52 controls received standard acute SRC management.

Conditions

Interventions

TypeNameDescription
DEVICEselective head-neck cooling using PolarCap systemPlayers receiving selective head-neck cooling after SRC

Timeline

Start date
2018-06-01
Primary completion
2020-06-01
Completion
2020-07-01
First posted
2021-01-08
Last updated
2021-01-08

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04701125. Inclusion in this directory is not an endorsement.